Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4

European Journal of Immunology
K SelmajC S Raine

Abstract

The effect of a novel TNF binding protein (TNFbp), a polyethylene glycol-linked form of the type I soluble receptor of TNF, on the expression of adhesion molecules has been investigated with a passive transfer model of experimental autoimmune encephalomyelitis (EAE) in SJL/J mice. The expression of L-selectin, VLA-4 and LFA-1 on spleen cells of EAE animals treated with TNFbp or saline was examined by FACS analysis. The expression of VCAM-1 and ICAM-1 was investigated by immunochemistry in spinal cord tissue of SJL/J mice with EAE. In animals sensitized for EAE and treated with TNFbp, the expression of VCAM-1 in the central nervous system as well as VLA-4 on spleen cells was clearly diminished. Reduction in VCAM-1 staining and VLA-4 expression corresponded to inhibition of inflammation in the spinal cord and to prevention of clinical signs of EAE. The results have also shown that myelin basic protein responses as well as non-antigen-specific responses were not diminished in animals treated with TNFbp. The findings suggest that TNFbp might prevent EAE development by modulating the expression of VCAM-1 and VLA-4.

References

Nov 1, 1991·Annals of Neurology·K SelmajA H Cross
Aug 15, 1991·The New England Journal of Medicine·M K Sharief, R Hentges
Mar 1, 1991·The Journal of Clinical Investigation·K SelmajC F Brosnan
Apr 1, 1995·Annals of Neurology·B Cannella, C S Raine
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·C P GenainS L Hauser
Jan 1, 1995·Advances in Immunology·B A Imhof, D Dunon
Mar 1, 1995·Nature Medicine·C S Raine
Jan 1, 1993·The Journal of Experimental Medicine·J L BaronC A Janeway
Jul 1, 1993·Journal of Neuroimmunology·B CannellaC S Raine
Nov 12, 1993·Science·T M KündigI Horak
Jan 1, 1996·Advances in Immunology·R Fernandez-BotranY Ma
Jun 16, 1997·The Journal of Experimental Medicine·L Steinman
Oct 23, 1997·The Journal of Experimental Medicine·W E SuenN H Ruddle

❮ Previous
Next ❯

Citations

Feb 5, 2003·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Hidefumi FukumitsuRihito Watanabe
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J L CroxfordD Baker
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D J CuaR L Coffman
Dec 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bruno GranAbdolmohamad Rostami
Jan 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·George S Deepe, Reta S Gibbons
Oct 14, 2014·BioMed Research International·Justin R SiebertDonna J Osterhout
Mar 30, 2002·Current Opinion in Neurology·Adre J du Plessis, Joseph J Volpe
Aug 22, 2013·Rheumatology·Thomas McDonnellAnisur Rahman
Nov 15, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·J F Eliason
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joyce S Hui-YuenRae S M Yeung
Mar 4, 2000·Journal of Neuroimmunology·J R KanwarG W Krissansen
Aug 3, 1999·Journal of Neuroimmunology·S J Lee, E N Benveniste

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.